Why Did ICL Group (ICL) Move Today?

Simply Wall St says ICL Group (NYSE:ICL) reported Q2 2026 sales of $2,135 million and net income of $137 million, and its board approved a new end-market operating model. The stock rose 9.90% over 30 days to $5.55 but is down 13.55% over 90 days. The article cites P/E 23.5x and a DCF value of $8.65.

Original reporting
Published Aug 16, 2026, 10:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 16, 2026, 10:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Did ICL Group (ICL) Move Today? — source image
Decision brief

The 30-second read

$ICLNeutralLow
01

Why it matters

For traders, the actionable element is the combination of reported earnings numbers and the operating-model approval, which can change expectations for segment focus and margins. However, the piece is largely valuation framing and does not provide new guidance or a quantified implementation timeline.

02

Market read

ICL is presented as rebounding on earnings clarity and operating-model change, but with persistent longer-term underperformance and cyclicality risk.

03

What to watch

The article does not quantify the operating-model’s expected cost savings or revenue uplift, so traders may be underpricing execution risk and timing uncertainty.

Relevance 4/10Novelty 4/10Timing: after-hours/late-day read-through of 2Q results and operating-model approval

Background

Simply Wall St discusses ICL’s 2Q 2026 results and a board-approved shift to a new end-market operating model, then compares valuation metrics to peers and the broader chemicals industry.

Company-level read

Ticker impact

$ICLNeutralMedium confidence
Context

ICL reported 2Q 2026 sales of $2,135M and net income of $137M, plus board approval for a new end-market operating model.

Expected impact

Near-term upside bias possible if investors buy into the operating-model execution, but follow-through depends on whether benefits materialize.

Evidence & confidence

The text provides concrete earnings figures and the board-approved operating-model shift, but it is still an interpretive valuation piece without new guidance or quantified benefit timeline.

Market effects

Signals ongoing investor focus on execution and operating-model clarity within diversified chemicals and specialty minerals.

No specific regional demand or policy linkage is provided in the article.

No explicit global macro or trade/regulatory catalyst is cited beyond general cyclicality risk.

Counterpoint

The valuation discussion (P/E vs peers and a DCF gap) may overstate opportunity if the operating-model benefits take longer to show up in earnings.

Key entities

  • ICL Group

    Reported 2Q 2026 sales of $2,135M and net income of $137M, and received board approval for a new end-market operating model.

Related articles

$ICLMedAI 8/10

ICL Group Ltd (ICL) Q3 2026 Earnings Call Highlights: Industrial Strength and Cost Cuts

ICL Group Ltd reported Q3 2026 earnings, with CEO Elad Aronson and CFO Assaf discussing market outlook, segment performance, and cost management. Key points include stable potash demand, rising phosphate fertilizer demand, and falling sulfur prices. Industrial products sales rose 18% YoY to $347M, with EBITDA up nearly 50%. Potash EBITDA declined 7% YoY due to higher costs. The company expects 2026 EBITDA to be within the $1.5B-$1.7B guidance range, with relief from sulfur costs in 2027.

$ICLMed

ICL Group Ltd Q3 2026 Earnings Call Summary

ICL Group Ltd reported Q3 2026 earnings, highlighting growth from strategic price increases and high-margin products. Key segments showed mixed results: Industrial Products benefited from bromine price increases, Phosphate Solutions saw resilience in specialty products, and Potash margins faced pressure. The company expects 2026 EBITDA of $1.5B-$1.7B and $150M EBITDA improvement in 2027 from cost-cutting.

$ICLMedAI 8/10

ICL Group Q3 Earnings Call Highlights

ICL Group reported Q3 average potash price at $370/ton, up 5% YoY. Phosphate Solutions sales were $589M, EBITDA $118M. Growing Solutions sales were $538M, EBITDA $44M. Sulfur costs rose 220% YoY, impacting Q4. ICL expects $150M EBITDA improvement by 2027. Company to reorganize segments in 2027. Maintained 2026 potash sales forecast of 4.5-4.7M metric tons. Paid $63M dividend in Q3.

$ICLHighAI 8/10

ICL Group (ICL) Q3 2026 Earnings Call Transcript

ICL Group reported Q3 2026 adjusted net income of $126M, up 2%, with EPS at $0.10. Operating cash flow was $256M, and free cash flow was $66M. Industrial Products sales rose 18% YoY, driven by higher bromine prices. Potash sales increased 4% YoY, but EBITDA fell 7% due to cost pressures. Phosphate Solutions sales were $589M with a 20% EBITDA margin, despite higher raw material costs. Growing Solutions sales were $538M with EBITDA of $44M, facing market challenges in Brazil.